SU1766262A3 - Способ получени гидрохлорида 14-трифторметансульфонилоксидауномицина - Google Patents
Способ получени гидрохлорида 14-трифторметансульфонилоксидауномицина Download PDFInfo
- Publication number
- SU1766262A3 SU1766262A3 SU904743426A SU4743426A SU1766262A3 SU 1766262 A3 SU1766262 A3 SU 1766262A3 SU 904743426 A SU904743426 A SU 904743426A SU 4743426 A SU4743426 A SU 4743426A SU 1766262 A3 SU1766262 A3 SU 1766262A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- hydrochloride
- salt
- formula
- adriamycin
- synthesis
- Prior art date
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title claims description 11
- 238000000034 method Methods 0.000 title claims description 7
- 230000015572 biosynthetic process Effects 0.000 title description 4
- 238000003786 synthesis reaction Methods 0.000 title description 4
- CZKMPDNXOGQMFW-UHFFFAOYSA-N chloro(triethyl)germane Chemical compound CC[Ge](Cl)(CC)CC CZKMPDNXOGQMFW-UHFFFAOYSA-N 0.000 claims 1
- 125000005951 trifluoromethanesulfonyloxy group Chemical group 0.000 claims 1
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 abstract description 12
- 229940009456 adriamycin Drugs 0.000 abstract description 6
- 229910052736 halogen Inorganic materials 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 150000003839 salts Chemical class 0.000 abstract 4
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000003495 polar organic solvent Substances 0.000 abstract 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 abstract 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 abstract 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- MWWSFMDVAYGXBV-RUELKSSGSA-N Doxorubicin hydrochloride Chemical group Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-RUELKSSGSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- -1 fluoro methane sulfone Chemical class 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- WVYWICLMDOOCFB-UHFFFAOYSA-N 4-methyl-2-pentanol Chemical compound CC(C)CC(C)O WVYWICLMDOOCFB-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QECVIPBZOPUTRD-UHFFFAOYSA-N N=S(=O)=O Chemical compound N=S(=O)=O QECVIPBZOPUTRD-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229940045799 anthracyclines and related substance Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical class O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N monofluoromethane Natural products FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- APVPOHHVBBYQAV-UHFFFAOYSA-N n-(4-aminophenyl)sulfonyloctadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 APVPOHHVBBYQAV-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- KJVQYDYPDFFJMP-UHFFFAOYSA-N sulfamethylthiazole Chemical compound CC1=CSC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 KJVQYDYPDFFJMP-UHFFFAOYSA-N 0.000 description 1
- 229950005939 sulfamethylthiazole Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22147488 | 1988-09-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1766262A3 true SU1766262A3 (ru) | 1992-09-30 |
Family
ID=16767284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU904743426A SU1766262A3 (ru) | 1988-09-06 | 1990-03-23 | Способ получени гидрохлорида 14-трифторметансульфонилоксидауномицина |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPH02167294A (enExample) |
| KR (1) | KR900004758A (enExample) |
| HU (1) | HU203113B (enExample) |
| SU (1) | SU1766262A3 (enExample) |
-
1988
- 1988-11-22 JP JP63293473A patent/JPH02167294A/ja active Granted
-
1989
- 1989-08-23 HU HU905753A patent/HU203113B/hu unknown
- 1989-09-06 KR KR1019890012891A patent/KR900004758A/ko not_active Withdrawn
-
1990
- 1990-03-23 SU SU904743426A patent/SU1766262A3/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0544958B2 (enExample) | 1993-07-07 |
| JPH02167294A (ja) | 1990-06-27 |
| KR900004758A (ko) | 1990-04-13 |
| HU905753D0 (en) | 1991-03-28 |
| HU203113B (en) | 1991-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI85493B (fi) | Foerfarande foer framstaellning av sackarosestrar. | |
| EP0041355B1 (en) | Novel erythromycin compounds | |
| EP0426653A1 (en) | 4-demethoxy-4-amino-anthracyclines | |
| SU1766262A3 (ru) | Способ получени гидрохлорида 14-трифторметансульфонилоксидауномицина | |
| EP0024727B1 (en) | Anthracycline glycosides, processes for their preparation and pharmaceutical composition containing them | |
| EP0199920B1 (en) | New antitumor anthracyclines | |
| US4865765A (en) | Ursodeoxycholic acid derivatives and their inorganic and organic salts having therapeutic activity, and process for preparing the same | |
| DK165790B (da) | Fremgangsmaade til fremstilling af adriamycin-4'-o-derivater eller syreadditionssalte deraf | |
| FI90777B (fi) | Menetelmä sytostaattisesti aktiivisten -rodomysinonijohdannaisten valmistamiseksi | |
| FI91762B (fi) | 4-substituoidut antrasyklinonit ja -antrasykliiniglykosidit ja niiden valmistaminen | |
| AU628478B2 (en) | 4'epi 4'amino anthracyclines | |
| DE2942818C2 (de) | 4'-C-Methyl-4'-O-methyl-daunorubicin und -doxorubicin und deren 4'-Epimere sowie diese Verbindungen enthaltende pharmazeutische Zusammensetzungen | |
| KR930003493B1 (ko) | 네틸마이신의 제조방법 | |
| CA1131218A (en) | Process for the preparation of new antitumor glycosides | |
| PT92637A (pt) | Processo para a preparacao de rodomicinas com uma unidade hidrato de carbono modificada | |
| RU2043360C1 (ru) | Антрациклин гликозиды или их фармацевтически приемлемые соли, обладающие противоопухолевыми свойствами, и способ их получения | |
| CA1229335A (en) | Process for the preparation of acylated sugars with a glycosidically bonded isothiocyanate group | |
| Wolfrom et al. | Thiosugars. II. Rearrangement of 2-(3, 4, 6-Tri-O-acetyl-2-amino-2-deoxy-β-D-glucopyranosyl)-2-thiop seudourea1a, b | |
| CN113801095B (zh) | 一种安罗替尼中间体的制备方法 | |
| SU1657054A3 (ru) | Способ получени солей 4,4 @ -динитростильбен-2,2 @ -дисульфокислоты | |
| US4997922A (en) | Anthracycline derivatives | |
| KR940004069B1 (ko) | 2,6-디데옥시-2-플루오로-l-타로피라노오스 또는 이의 유도체와 그 제조법 | |
| RU1651523C (ru) | Способ получени диацетонакриламида | |
| JPH0586800B2 (enExample) | ||
| US5602108A (en) | Semisynthetic diastereomerically pure N-glycidylanthracyclines, a process for the stereoselective preparation thereof as the use thereof as cytostatics |